MedTrace Logo

Late Organ Specific Adverse Effects hiPec or pElvic eXenteration

NCT04970316 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2023-02-28

No results posted yet for this study

Summary

The purpose of this study is to describe type and extent of organ specific late adverse effects in patients undergoing surgery for colorectal cancer with peritoneal metastases and after surgery for colorectal cancer with involvement of the urinary bladder.

Conditions

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • Skane University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Rogini Balachandran, MD · Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04970316 on ClinicalTrials.gov